Literature DB >> 7737197

Ribosome-inactivating proteins (RNA N-glycosidases) from the seeds of Saponaria ocymoides and Vaccaria pyramidata.

A Bolognesi1, F Olivieri, M G Battelli, L Barbieri, A I Falasca, A Parente, F Del Vecchio Blanco, F Stirpe.   

Abstract

From the seeds of the Caryophyllaceae Saponaria ocymoides and Vaccaria pyramidata two proteins were purified which have the properties of the type-1 (single-chain) ribosome-inactivating proteins [reviewed by Barbieri, L., Battelli, M. G. & Stirpe, F. (1993) Ribosome-inactivating proteins from plants, Biochim. Biophys. Acta 1154, 237-282]. The proteins have molecular masses of 30.2 kDa (S. ocymoides) and 28.0 kDa (V. pyramidata) and pI greater than 9.5, their N-terminal amino acid sequences are similar to those of saporin-S6 and dianthin 30, ribosome-inactivating proteins from other Caryophyllaceae, and they partially cross-react with sera against these proteins. Both proteins inhibit protein synthesis by a rabbit-reticulocyte lysate with IC50 (concentrations giving 50% inhibition) below 10(-10) M, have a smaller effect on poly(U)-directed phenylalanine polymerisation by rat liver ribosomes (nanomolar IC50, approximately) and on protein synthesis by various cell lines (IC50 ranging from 4 nM to > 3000 nM) and possess rRNA N-glycosidase activity, releasing 1 mol adenine/ribosome.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7737197     DOI: 10.1111/j.1432-1033.1995.tb20343.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  9 in total

1.  Effects of protein synthesis inhibitors on the sensitization of a defensive response in common snails and potentiation of the cholinosensitivity of command neurons.

Authors:  M S Abramova; A A Moskvitin; A S Pivovarov
Journal:  Neurosci Behav Physiol       Date:  2007-06

2.  Immunoconjugates made of an anti-EGF receptor monoclonal antibody and type 1 ribosome-inactivating proteins from Saponaria ocymoides or Vaccaria pyramidata.

Authors:  A M Di Massimo; M Di Loreto; A Pacilli; G Raucci; L D'Alatri; A Mele; A Bolognesi; L Polito; F Stirpe; R De Santis
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 3.  Ribosome-inactivating and related proteins.

Authors:  Joachim Schrot; Alexander Weng; Matthias F Melzig
Journal:  Toxins (Basel)       Date:  2015-05-08       Impact factor: 4.546

Review 4.  Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy.

Authors:  Roger Gilabert-Oriol; Alexander Weng; Benedicta von Mallinckrodt; Matthias F Melzig; Hendrik Fuchs; Mayank Thakur
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 5.  Hyperuricaemia, Xanthine Oxidoreductase and Ribosome-Inactivating Proteins from Plants: The Contributions of Fiorenzo Stirpe to Frontline Research.

Authors:  Andrea Bolognesi; Massimo Bortolotti; Maria Giulia Battelli; Letizia Polito
Journal:  Molecules       Date:  2017-01-27       Impact factor: 4.411

Review 6.  Dianthin and Its Potential in Targeted Tumor Therapies.

Authors:  Hendrik Fuchs
Journal:  Toxins (Basel)       Date:  2019-10-11       Impact factor: 4.546

Review 7.  The Updated Review on Plant Peptides and Their Applications in Human Health.

Authors:  Saiprahalad Mani; Smruti B Bhatt; Vinduja Vasudevan; Dhamodharan Prabhu; Sundararaj Rajamanikandan; Palaniyandi Velusamy; Palaniappan Ramasamy; Pachaiappan Raman
Journal:  Int J Pept Res Ther       Date:  2022-07-27       Impact factor: 2.191

8.  Sapovaccarin-S1 and -S2, Two Type I RIP Isoforms from the Seeds of Saponaria vaccaria L.

Authors:  Louisa Schlaak; Christoph Weise; Benno Kuropka; Alexander Weng
Journal:  Toxins (Basel)       Date:  2022-06-30       Impact factor: 5.075

9.  An unusual type I ribosome-inactivating protein from Agrostemma githago L.

Authors:  Christoph Weise; Achim Schrot; Leonie T D Wuerger; Jacob Adolf; Roger Gilabert-Oriol; Simko Sama; Matthias F Melzig; Alexander Weng
Journal:  Sci Rep       Date:  2020-09-21       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.